| 股票代码 | 300016 | 当期评分 | ||||
| 股票名称 | 北陆药业 | |||||
| 报告日期 | 2018-12-31 | 2019-12-31 | 2020-03-31 | 2020-06-30 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | 0.3594 | 0.317 | 0.1103 | 0.131 | 0.2277 | ✔ |
| 销售净利润率(%) | 24.3008 | 41.8057 | 20.1782 | 23.1257 | 24.1841 | ✔ |
| 销售毛利率(%) | 65.5047 | 67.7129 | 65.8645 | 64.3696 | 65.0485 | ✔ |
| 净资产收益率(%) | 12.25 | 23.61 | 1.81 | 6.05 | 10.12 | ✘ |
| 营业增长率(%) | 16.3654 | 34.7117 | -27.0822 | -8.4392 | 2.6231 | ✔ |
| 净利润增长率(%) | 24.3612 | 131.7501 | -37.4348 | -24.1091 | -9.7829 | ✔ |
| 每股收益(%) | 0.3 | 0.7 | 0.054 | 0.19 | 0.3282 | ✔ |
| 现金流量比率(%) | 282.8211 | 124.5605 | 39.7921 | 27.2586 | 34.866 | ✔ |
| 三项费用比重(%) | 36.8075 | 38.867 | 37.8551 | 37.4262 | 36.2784 | ✔ |
| 每股净资产(¥) | 2.4659 | 2.9322 | 2.9899 | 3.0607 | 3.2071 | ✔ |
| 流动比率(%) | 7.1476 | 4.376 | 4.3933 | 2.9199 | 2.5016 | ✔ |
| 速动比率(%) | 5.6327 | 3.4042 | 3.2785 | 2.421 | 2.1025 | ✔ |
| 现金比率(%) | 307.4251 | 197.3193 | 225.6936 | 145.1153 | 145.1153 | ✔ |
| 总资产利润率(%) | 12.1635 | 23.5148 | 1.4275 | 4.6244 | 7.8727 | ✔ |
| 主营利润比重% | 241.5946 | 139.7911 | 266.3911 | 244.1194 | 237.304 | ✔ |
| 应收账款(万元) | 13,401.85 | 15,931.93 | 10,277.08 | 19,409.44 | 22,001.16 | ✔ |
| 应收票据(万元) | 1,489.99 | 320.75 | 386.91 | 649.18 | 40.00 | ✔ |
| 预付款项(万元) | 279.16 | 681.75 | 776.70 | 1,023.75 | 1,578.82 | ✔ |
| 存货(万元) | 9,413.89 | 12,233.91 | 15,289.03 | 11,859.67 | 12,891.19 | ✘ |
| 在建工程(万元) | 7,402.74 | 268.10 | 24,021.14 | 27,233.07 | 29,975.36 | ✔ |
| 应付款项(万元) | 2,924.49 | 5,529.49 | 5,499.31 | 4,047.57 | 5,887.90 | ✘ |
| 长期借款(万元) | -- | -- | 7,700.00 | 7,710.75 | 7,710.75 | ✔ |
| 未分配利润(万元) | 43,293.44 | 69,486.53 | 72,024.56 | 75,181.03 | 82,075.10 | ✔ |
| 商誉(万元) | -- | -- | 5,941.26 | 5,122.60 | 5,122.60 | ✔ |
| 流动资产(万元) | 84,454.52 | 107,292.88 | 132,957.49 | 135,878.19 | 139,915.36 | ✘ |
| 流动负债(万元) | 6,214.32 | 12,588.96 | 13,714.88 | 23,773.43 | 32,300.54 | ✘ |
北陆药业300016评分结果 | 81.82分 | 买入/增持 | ||||